Skip to main content
Top
Published in: BMC Neurology 1/2016

Open Access 01-12-2016 | Case report

Late-onset spinal form xanthomatosis without brain lesion: a case report

Authors: Masaru Yanagihashi, Osamu Kano, Tomoya Terashima, Yuji Kawase, Sayori Hanashiro, Masahiro Sawada, Yuichi Ishikawa, Nobuyuki Shiraga, Ken Ikeda, Yasuo Iwasaki

Published in: BMC Neurology | Issue 1/2016

Login to get access

Abstract

Background

Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive sterol storage disease caused by a mutated sterol 27-hydroxylase (CYP27A1) gene. Patients with typical CTX show neurological dysfunction including bilateral cataracts, paresis, cerebral ataxia, dementia, and psychiatric disorders, and magnetic resonance imaging (MRI) has revealed symmetrical lesions in the cerebellar white matter.

Case presentation

We report the case of a patient with late-onset spinal form CTX without brain lesion. He showed pyramidal tract signs, and impaired joint position and vibration sensation in the lower limbs. Cervical sagittal MRI demonstrated a longitudinally extensive white matter abnormality in the dorsal column of the C2-C7 spinal cord; however, a brain MRI revealed an absence of lesions, including in the cerebellar white matter. Genetic analysis of CYP27A1 revealed that the patient was compound heterozygous for p.Gln85Arg in exon 1, a novel mutation, and p.Arg405Gln in exon 7, a previously reported mutation.

Conclusion

This is the first report of late-onset spinal form CTX without typical neurological symptoms, and the first report of p.Gln85Arg in CYP27A1. We speculate that spinal form CTX without brain lesion is a clinically and radiologically rare variation of CTX. Therefore, spinal xanthomatosis should be included in the differential diagnosis of chronic myelopathy even with late-onset and/or no other typical neurological findings.
Literature
1.
go back to reference Bjorkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease, vol. 2. 7th ed. New York: McGraw-Hill Inc; 1995. p. 2073–99. Bjorkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease, vol. 2. 7th ed. New York: McGraw-Hill Inc; 1995. p. 2073–99.
2.
go back to reference Cruysberg JR, Wevers RA, Tolboom JJ. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol. 1991;112(5):606–7.CrossRefPubMed Cruysberg JR, Wevers RA, Tolboom JJ. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol. 1991;112(5):606–7.CrossRefPubMed
3.
go back to reference Cruysberg JR, Wevers RA, van Engelen BG, Pinckers A, van Spreeken A, Tolboom JJ. Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol. 1995;120(5):597–604.CrossRefPubMed Cruysberg JR, Wevers RA, van Engelen BG, Pinckers A, van Spreeken A, Tolboom JJ. Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol. 1995;120(5):597–604.CrossRefPubMed
4.
go back to reference Barkhof F, Van BGM, Verrips A, GJL A. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain : a journal of neurology. 1999;122(Pt 8):1589–95. Barkhof F, Van BGM, Verrips A, GJL A. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain : a journal of neurology. 1999;122(Pt 8):1589–95.
5.
go back to reference Abe R, Sekijima Y, Kinoshita T, Yoshinaga T, Koyama S, Kato T, Ikeda SI: Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion. The journal of spinal cord medicine 2015. Epub ahead of print. Abe R, Sekijima Y, Kinoshita T, Yoshinaga T, Koyama S, Kato T, Ikeda SI: Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion. The journal of spinal cord medicine 2015. Epub ahead of print.
6.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed
7.
go back to reference Suh S, Kim HK, Park HD, Ki CS, Kim MY, Jin SM, et al. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene. Eur J Med Genet. 2012;55(1):71–4.CrossRefPubMed Suh S, Kim HK, Park HD, Ki CS, Kim MY, Jin SM, et al. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene. Eur J Med Genet. 2012;55(1):71–4.CrossRefPubMed
8.
go back to reference Yoshinaga T, Sekijima Y, Koyama S, Maruyama K, Yoshida T, Kato T, et al. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene. Intern Med. 2014;53(23):2725–9.CrossRefPubMed Yoshinaga T, Sekijima Y, Koyama S, Maruyama K, Yoshida T, Kato T, et al. Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene. Intern Med. 2014;53(23):2725–9.CrossRefPubMed
9.
go back to reference Nicholls Z, Hobson E, Martindale J, Shaw PJ. Diagnosis of spinal xanthomatosis by next-generation sequencing: identifying a rare, treatable mimic of hereditary spastic paraparesis. Pract Neurol. 2015;15(4):280–3.CrossRefPubMed Nicholls Z, Hobson E, Martindale J, Shaw PJ. Diagnosis of spinal xanthomatosis by next-generation sequencing: identifying a rare, treatable mimic of hereditary spastic paraparesis. Pract Neurol. 2015;15(4):280–3.CrossRefPubMed
10.
go back to reference Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism. 1991;40(7):741–6.CrossRefPubMed Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism. 1991;40(7):741–6.CrossRefPubMed
11.
go back to reference Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311(26):1649–52.CrossRefPubMed Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med. 1984;311(26):1649–52.CrossRefPubMed
12.
go back to reference Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci. 1991;102(2):225–32.CrossRefPubMed Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci. 1991;102(2):225–32.CrossRefPubMed
13.
go back to reference Sawada N, Yamamoto K, Yamada S, Ikushiro S, Kamakura M, Ohta M, et al. Role of Gln 85 of human CYP27A1 in 25-hydroxyvitamin D(3)-binding and protein folding. Biochem Biophys Res Commun. 2007;355(1):211–6.CrossRefPubMed Sawada N, Yamamoto K, Yamada S, Ikushiro S, Kamakura M, Ohta M, et al. Role of Gln 85 of human CYP27A1 in 25-hydroxyvitamin D(3)-binding and protein folding. Biochem Biophys Res Commun. 2007;355(1):211–6.CrossRefPubMed
14.
go back to reference Lewis B, Mitchell WD, Marenah CB, Cortese C, Reynolds EH, Shakir R. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. Br Med J. 1983;287(6384):21–2.CrossRef Lewis B, Mitchell WD, Marenah CB, Cortese C, Reynolds EH, Shakir R. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. Br Med J. 1983;287(6384):21–2.CrossRef
Metadata
Title
Late-onset spinal form xanthomatosis without brain lesion: a case report
Authors
Masaru Yanagihashi
Osamu Kano
Tomoya Terashima
Yuji Kawase
Sayori Hanashiro
Masahiro Sawada
Yuichi Ishikawa
Nobuyuki Shiraga
Ken Ikeda
Yasuo Iwasaki
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0542-2

Other articles of this Issue 1/2016

BMC Neurology 1/2016 Go to the issue